Authors

Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors

Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients.

Caffeine vs Guarana: Can AI Predict Which Stimulant Packs the Bigger Punch?

AI-driven analysis reveals guarana offers more sustained cognitive stimulation than caffeine, due to additional bioactive compounds and slower caffeine release kinetics.

Pharmacists Can Advance Lung Cancer Screening Awareness in High-Risk Patients

Pharmacists can help close the lung cancer screening gap by identifying high-risk tobacco users, increasing awareness, and connecting eligible patients to lifesaving early detection.

Pharmacists’ Role in Antibiotic Stewardship: Understanding Spectrums to Combat Resistance

Pharmacists ensure responsible antibiotic use, combating resistance through tailored therapies.

Leveraging Technology to Enhance Women’s Health and Access to Care

Panelists discuss how digital health technologies revolutionize women’s health care through telehealth, mobile apps, and remote monitoring, expanding access, personalization, and proactive medical support.

RSV in Older Adults: The More You Know, the Better Off Your Patients Will Be

Respiratory syncytial virus hits older adults hard and is often missed. Learn symptoms, testing, and how new vaccines and pharmacists help prevent severe illness.

Evaluating Iron Sucrose Discordance: A Retrospective Health System Review

After transitioning iron sucrose 200 mg from an infusion to intravenous push, the incidence of discordance and infusion reactions were not statistically different.

From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements

Pharmacists guide consumers in selecting quality dietary supplements, emphasizing the importance of USP verification for safety and efficacy.

OTC Case Studies: Supplements for Aging

Explore essential supplement recommendations for older adults, including vitamin D, calcium, melatonin, and multivitamins, to enhance health and well-being.

What’s New in OTC and How to Help Patients Choose the Right Product

Renee’ Acosta, RPh, MS, discusses recent developments in the OTC market and key considerations pharmacy staff should prioritize when guiding patients in selecting appropriate over-the-counter therapies.

Understanding The Independent Pharmacy Data Economy

Independent pharmacies are being squeezed on reimbursement while their data quietly fuels billion-dollar decisions. A new pharmacy data economy could flip that script.

School of Pharmacy Duo Places Second in National Clinical Skills Competition

MHC Class II Peptide Binding Prediction: Challenges, AlphaFold 3, and ESM2 Explained

Pharmacy Times interviews Kamel Lahouel, PhD, and Cristian Tomasetti, PhD, on the challenges of predicting MHC class II peptide binding and how combining structural and sequence-based models can improve accuracy while addressing key limitations.

The Controversial 340B Rebate Pilot Program Is Moving Forward

HRSA moves forward with the 340B Rebate Model Pilot Program, raising concerns among health care providers about financial impacts and operational challenges.

Study Reveals Virtual Reality Effectively Educates Pharmacists on Continuous Glucose Monitors

Community pharmacists are uniquely positioned to assist with diabetes management using CGM devices.

The July Spike in Ordering Errors: A Call for Proactive Pharmacy Involvement

Pharmacists play a critical role in preventing medication ordering errors during residency onboarding through proactive training, system safeguards, and interdisciplinary collaboration.

Staying in the Know: Pharmacists, Drug Shortages, and What Lies Ahead

Pharmacists should be aware of current discussions, attempted fixes, and expected length of drug shortages.

Clearing the Air: The Influence of Vaping on Smoking Cessation

Pharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.

The Expanding Role of CDK 4/6 Inhibitors in Breast Cancer Treatment

Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have transformed the treatment of hormone receptor-positive/HER2-negative breast cancer across metastatic and early-stage settings, with ongoing research exploring their potential in additional breast cancer subtypes, combination therapies, and aggressive disease scenarios.

Bortezomib Off-Week Regimen Shows Promise for Reducing Toxicity in Multiple Myeloma

Erin Harrell, PharmD, offers insights about managing peripheral neuropathy in patients receiving bortezomib.

Impact of Time to First Epinephrine Administration on Outcomes After In-Hospital Cardiac Arrest With Initial Nonshockable Rhythm

This study found no significant difference in the sustained return of spontaneous circulation or survival to hospital discharge based on the timing of the first epinephrine administration in these patients.

Maximum Dose, Minimal Gain: Rethinking Antihypertensive Dose Titration

Awareness of the nonlinear response helps ensure patients are treated with the least intensive regimen that achieves meaningful control while minimizing harm and improving long-term therapeutic success.

The Future of Top-Selling Biologics: Biosimilars on the Rise

Key Insights From the 2025 World Drug Safety Congress Europe

Artificial intelligence, real-world data, and patient voices reshape pharmacovigilance, helping pharmacists spot risks faster and strengthen life cycle drug safety.

Exploring the Antidepressant Potential of GLP-1 Receptor Agonists

GLP-1 receptor agonists show promise in alleviating depressive symptoms in patients with type 2 diabetes, offering a potential dual benefit in treatment.

Pembrolizumab-Induced Adrenal Insufficiency: Recognizing and Managing a Diagnostic Challenge in Adjuvant NSCLC Therapy

Pembrolizumab in adjuvant NSCLC therapy can trigger central adrenal insufficiency with vague fatigue, nausea, and hyponatremia.

Revolutionizing Treatment with Bispecific Therapies: Navigating the Challenges Ahead

By decade’s end, approval of additional bispecifics is expected for hematological malignancies, solid tumors, and non-oncology conditions such as inflammatory, autoimmune, neurodegenerative and vascular diseases, and ocular disorders and infections.

A New Therapeutic Era in Metastatic Castration-Resistant Prostate Cancer

Emerging targets are reshaping how mCRPC is treated, as showcased at the 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium.

Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors

Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients.

Pharmacists Leading the Treatment of Multiple Myeloma: Precision Therapy and Collaborative Oncology Care

Evolving myeloma therapies and pharmacist-led care reshape outcomes, tackling resistance, toxicity, and personalized treatment sequencing.